Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$122.82
al cierre: Aug 12 EDT
$122.90
0.080.07%
Pre-comercialización: 7:20 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Clorox Co ha un obiettivo di prezzo di consenso pari a $142.63, stabilito in base alle ultime valutazioni degli analisti di 21. Le ultime 3 valutazioni degli analisti sono state rilasciate da Morgan Stanley, Wells Fargo y JP Morgan il agosto 1, 2025, agosto 1, 2025 y julio 25, 2025. Con un obiettivo di prezzo medio di $138.33 tra le Morgan Stanley, Wells Fargo y JP Morgan, c'è un implicito 12.56% upside per Clorox Co da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Morgan Stanley
Wells Fargo
JP Morgan
UBS
Citigroup
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Clorox
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/01/2025 | 11.47% | Morgan Stanley | $150 → $137 | Maintains | Equal-Weight | |||
08/01/2025 | 12.29% | Wells Fargo | $135 → $138 | Maintains | Equal-Weight | |||
07/25/2025 | 13.91% | JP Morgan | $144 → $140 | Maintains | Neutral | |||
07/17/2025 | 9.03% | UBS | $150 → $134 | Maintains | Neutral | |||
07/15/2025 | 9.85% | Citigroup | $140 → $135 | Maintains | Neutral | |||
07/15/2025 | -3.17% | Barclays | $129 → $119 | Maintains | Underweight | |||
07/09/2025 | 9.85% | Wells Fargo | $142 → $135 | Maintains | Equal-Weight | |||
06/26/2025 | 17.98% | Jefferies | $167 → $145 | Maintains | Buy | |||
05/07/2025 | 4.96% | Barclays | $134 → $129 | Maintains | Underweight | |||
05/06/2025 | 22.05% | Morgan Stanley | $165 → $150 | Maintains | Equal-Weight | |||
05/06/2025 | 15.54% | Wells Fargo | $145 → $142 | Maintains | Equal-Weight | |||
05/06/2025 | 17.17% | JP Morgan | $151 → $144 | Maintains | Neutral | |||
04/17/2025 | 25.31% | UBS | $176 → $154 | Maintains | Neutral | |||
04/16/2025 | 17.98% | Wells Fargo | $155 → $145 | Maintains | Equal-Weight | |||
04/14/2025 | 22.05% | Citigroup | $165 → $150 | Maintains | Neutral | |||
04/11/2025 | 9.03% | Barclays | $139 → $134 | Maintains | Underweight | |||
04/11/2025 | 22.86% | JP Morgan | $173 → $151 | Maintains | Neutral | |||
04/02/2025 | 26.12% | Wells Fargo | $161 → $155 | Maintains | Equal-Weight | |||
03/27/2025 | 13.1% | Barclays | $140 → $139 | Maintains | Underweight | |||
02/05/2025 | 13.91% | Barclays | $130 → $140 | Maintains | Underweight | |||
02/05/2025 | 37.51% | DA Davidson | $171 → $169 | Maintains | Neutral | |||
02/04/2025 | 40.76% | JP Morgan | $171 → $173 | Maintains | Neutral | |||
02/04/2025 | 31% | Wells Fargo | $157 → $161 | Maintains | Equal-Weight | |||
01/30/2025 | 22.05% | RBC Capital | $150 → $150 | Reiterates | Sector Perform → Sector Perform | |||
01/17/2025 | 5.78% | Barclays | $139 → $130 | Maintains | Underweight | |||
01/16/2025 | 39.14% | JP Morgan | $167 → $171 | Maintains | Neutral | |||
01/07/2025 | 27.75% | Wells Fargo | $155 → $157 | Upgrade | Underweight → Equal-Weight | |||
11/06/2024 | 38.32% | TD Cowen | $155 → $170 | Upgrade | Sell → Hold | |||
11/04/2024 | 39.14% | DA Davidson | $153 → $171 | Maintains | Neutral | |||
11/01/2024 | 13.1% | Barclays | $137 → $139 | Maintains | Underweight | |||
10/14/2024 | 13.1% | Evercore ISI Group | $140 → $139 | Maintains | Underperform | |||
10/11/2024 | 11.47% | Barclays | $130 → $137 | Maintains | Underweight | |||
10/11/2024 | 41.58% | JP Morgan | $148 → $174 | Maintains | Neutral | |||
10/01/2024 | 52.16% | Jefferies | $174 → $187 | Upgrade | Hold → Buy | |||
09/06/2024 | 38.32% | Citigroup | $165 → $170 | Maintains | Neutral | |||
09/06/2024 | 24.49% | DA Davidson | $153 → $153 | Maintains | Neutral | |||
08/28/2024 | 34.26% | Citigroup | $145 → $165 | Maintains | Neutral | |||
08/05/2024 | 5.78% | Barclays | $122 → $130 | Maintains | Underweight | |||
08/02/2024 | 24.49% | DA Davidson | $162 → $153 | Maintains | Neutral | |||
08/02/2024 | 20.42% | JP Morgan | $150 → $148 | Maintains | Neutral | |||
08/02/2024 | 22.86% | Deutsche Bank | $144 → $151 | Maintains | Hold | |||
07/23/2024 | -0.73% | TD Cowen | → $122 | Initiates | → Sell | |||
07/22/2024 | 22.05% | JP Morgan | $158 → $150 | Maintains | Neutral | |||
07/19/2024 | -0.73% | Barclays | $132 → $122 | Maintains | Underweight | |||
07/10/2024 | 17.98% | Citigroup | $150 → $145 | Maintains | Neutral | |||
07/10/2024 | 5.78% | Wells Fargo | $135 → $130 | Maintains | Underweight | |||
06/24/2024 | 5.78% | Exane BNP Paribas | → $130 | Initiates | → Underperform | |||
05/02/2024 | 9.85% | Wells Fargo | $140 → $135 | Maintains | Underweight | |||
05/02/2024 | 7.4% | Barclays | $136 → $132 | Maintains | Underweight | |||
05/01/2024 | 22.05% | Citigroup | $155 → $150 | Maintains | Neutral | |||
05/01/2024 | 29.37% | UBS | $164 → $159 | Maintains | Neutral | |||
05/01/2024 | 28.56% | JP Morgan | $159 → $158 | Maintains | Neutral | |||
05/01/2024 | 15.54% | Evercore ISI Group | $145 → $142 | Maintains | Underperform | |||
04/17/2024 | 22.86% | Deutsche Bank | $155 → $151 | Maintains | Hold | |||
04/17/2024 | 31.81% | DA Davidson | $162 → $162 | Maintains | Neutral | |||
04/16/2024 | 26.12% | Citigroup | $165 → $155 | Maintains | Neutral | |||
04/10/2024 | 10.66% | Barclays | $148 → $136 | Maintains | Underweight | |||
04/02/2024 | 34.26% | Citigroup | $170 → $165 | Downgrade | Buy → Neutral | |||
03/26/2024 | 30.19% | Morgan Stanley | $160 → $160 | Maintains | Equal-Weight | |||
03/26/2024 | 17.98% | Jefferies | → $145 | Upgrade | Underperform → Hold | |||
03/01/2024 | 13.91% | Goldman Sachs | → $140 | Reinstates | → Sell | |||
02/05/2024 | 31.81% | DA Davidson | → $162 | Downgrade | Buy → Neutral | |||
02/02/2024 | 38.32% | UBS | $145 → $170 | Maintains | Neutral | |||
01/18/2024 | 23.68% | JP Morgan | $145 → $152 | Maintains | Neutral | |||
01/16/2024 | -3.99% | Barclays | $115 → $118 | Maintains | Underweight | |||
12/15/2023 | 22.05% | B of A Securities | $120 → $150 | Upgrade | Underperform → Neutral | |||
11/22/2023 | 17.98% | JP Morgan | $124 → $145 | Upgrade | Underweight → Neutral | |||
11/17/2023 | 31.81% | DA Davidson | $152 → $162 | Maintains | Buy | |||
11/13/2023 | -4.8% | Jefferies | → $117 | Initiates | → Underperform | |||
11/06/2023 | 7.4% | UBS | $124 → $132 | Upgrade | Sell → Neutral | |||
11/02/2023 | 22.05% | Citigroup | $135 → $150 | Upgrade | Neutral → Buy | |||
10/12/2023 | -2.36% | Bernstein | → $120 | Upgrade | Underperform → Market Perform | |||
10/11/2023 | 9.85% | Citigroup | $170 → $135 | Maintains | Neutral | |||
10/05/2023 | -2.36% | Evercore ISI Group | $160 → $120 | Maintains | Underperform | |||
10/05/2023 | 0.9% | JP Morgan | $152 → $124 | Maintains | Underweight | |||
10/05/2023 | -2.36% | B of A Securities | $145 → $120 | Maintains | Underperform | |||
10/05/2023 | — | Raymond James | — | Downgrade | Outperform → Market Perform | |||
10/02/2023 | 23.68% | DA Davidson | → $152 | Upgrade | Neutral → Buy | |||
09/22/2023 | 18.8% | HSBC | → $146 | Initiates | → Hold | |||
09/19/2023 | 23.68% | DA Davidson | $176 → $152 | Maintains | Neutral | |||
09/19/2023 | 13.91% | Wells Fargo | $150 → $140 | Maintains | Underweight | |||
08/07/2023 | 43.21% | DA Davidson | $155 → $176 | Maintains | Neutral | |||
08/04/2023 | 3.34% | Barclays | $117 → $127 | Maintains | Underweight | |||
08/03/2023 | — | Atlantic Equities | — | Upgrade | Underweight → Neutral | |||
07/20/2023 | -4.8% | Barclays | $124 → $117 | Maintains | Underweight | |||
07/11/2023 | 38.32% | Citigroup | → $170 | Reiterates | Neutral → Neutral | |||
05/08/2023 | 26.12% | DA Davidson | → $155 | Reiterates | → Neutral | |||
05/04/2023 | 39.14% | Morgan Stanley | $145 → $171 | Maintains | Equal-Weight | |||
05/04/2023 | -3.99% | Barclays | $113 → $118 | Maintains | Underweight | |||
05/03/2023 | 13.91% | B of A Securities | $130 → $140 | Maintains | Underperform | |||
05/03/2023 | 22.86% | RBC Capital | $137 → $151 | Maintains | Sector Perform | |||
05/03/2023 | 22.05% | Wells Fargo | $145 → $150 | Maintains | Underweight | |||
05/03/2023 | 50.53% | Raymond James | $165 → $185 | Maintains | Outperform | |||
04/18/2023 | 21.24% | Deutsche Bank | $147 → $149 | Maintains | Hold | |||
04/14/2023 | -8.06% | Barclays | $108 → $113 | Maintains | Underweight | |||
04/12/2023 | 17.98% | Wells Fargo | $135 → $145 | Maintains | Underweight | |||
04/06/2023 | 20.42% | UBS | $140 → $148 | Maintains | Sell | |||
03/20/2023 | 19.61% | Deutsche Bank | $152 → $147 | Maintains | Hold | |||
02/06/2023 | -12.12% | Barclays | $110 → $108 | Maintains | Underweight | |||
02/03/2023 | 17.98% | Morgan Stanley | $142 → $145 | Maintains | Equal-Weight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Clorox (CLX)?
El último precio objetivo de Clorox (NYSE:CLX) fue comunicado por Morgan Stanley el agosto 1, 2025. La firma de analistas fijó un precio objetivo para $137.00 que espera CLX a rise dentro de 12 meses (un posible 11.47% upside). 37 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Clorox (CLX)?
La última calificación de analistas para Clorox (NYSE:CLX) fue proporcionada por Morgan Stanley, y Clorox mantuvo su equal-weight calificación.
¿Cuándo se produjo la última revisión al alza de Clorox (CLX)?
La última revisión al alza de Clorox Co se produjo en enero 7, 2025, cuando Wells Fargo elevó su precio objetivo a $157. Wells Fargo anteriormente tenía an underweight para Clorox Co.
¿Cuándo fue la última revisión a la baja de Clorox (CLX)?
La última revisión a la baja de Clorox Co se produjo en abril 2, 2024, cuando Citigroup cambió su precio objetivo de $170 a $165 para Clorox Co.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Clorox (CLX)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Clorox, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Clorox se registró el agosto 1, 2025, por lo que la próxima calificación estará disponible en torno al agosto 1, 2026.
¿Es correcta la calificación de los analistas sobre Clorox (CLX)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Clorox (CLX) fue un mantuvo con un precio objetivo de $150.00 a $137.00. El precio actual al que cotiza Clorox (CLX) es de $122.90, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.